# Micell Technologies

Organization · id `cardio:org-micell-technologies` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov sponsor names](<https://clinicaltrials.gov/search?spons=Micell+Technologies>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 3 trials in this atlas.

## Technical summary

Sponsor class industry. No ROR record matches the name exactly.

## The registry's words

- Sponsor name: Micell Technologies
- Sponsor class: INDUSTRY

## Connected pages

- Sponsors: Clinical Investigation of the MiStent Drug Eluting Stent (DES) in Coronary Artery Disease (`cardio:ct-nct01294748`)
- Sponsors: Trial of MiStent Compared to Xience in Japan (`cardio:ct-nct02972671`)
- Sponsors: Trial to Demonstrate the Safety and Effectiveness of the MiStent II for the Revascularization of Coronary Arteries. (`cardio:ct-nct03423511`)

## Provenance

Content hash: db9e5f64590c297bbc3287b423cd7151c0f9a3f4eff8e0469885ea7bca860b4c
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
